Antonio Giordano

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Antonio Giordano
051807 DrAntonioGiordano007.JPG
Antonio Giordano
Born (1962-10-11) October 11, 1962 (age 58)
Naples, Campania, Italy
NationalityItalian and American
Alma materUniversity of Naples Federico II
AwardsKnight and Commander of Order of Merit of the Italian Republic; Cross of Merit Melitense from Sovereign Military Order of Malta
Scientific career
FieldsOncology
Institutions

Antonio Giordano (Napoli, 11 Ottobre 1962 ) is a Oncologist, pathologist, geneticist, researcher, university professor e writer Italian naturalized American

Director of the Sbarro Institute for Cancer Research and Molecular Medicine in Philadelphia, and professor of Anatomy and Pathological Histology at the Department of Medical Biotechnology of the University of Siena. Among his many research activities there is the one aimed at activism in the context of the denunciation of environmental factors that cause an increase in cancer pathologies. The commitment of Prof. Giordano has its origins in numerous scientific works. He worked as post doctoral fellow at Cold Spring Harbor  laboratory directed by Nobel Prize winner James Dewey Watson,[1] he discovered some key factors in the regulation of the cell cycle, of the mechanisms linked to the onset of tumors and he linked his career as a researcher to that of a scientific popularizer, mainly engaging in making the link known between the environment polluted by toxic waste and the increased risk of the onset of cancer for the population of the Campania Region. During his career, he distinguished himself for having isolated the tumor suppressor gene, the RB2/p130,[2][3] subsequently demonstrating how the same gene, introduced through a retrovirus in some animal models, is able to reduce the growth of tumors.[4]

Biography[edit]

Antonio Giordano, is the son of Giovan Giacomo Giordano (Corbara 1925 - 2010), oncologist and pathologist and of Maria Teresa Sgambati. He graduated with full marks in Medicine at the University of Naples in 1986. He obtained a specialization in Anatomy and Pathological Histology at the University of Trieste. He later moved to the United States for a PhD, where he was a student of Nobel Prize James Dewey Watson at Cold Spring Harbor Laboratory. In those years he discovered the direct link between cell cycle regulation and the development of cancer. More specifically, he demonstrated that, in order for normal cells to transform into neoplastic, oncogenes must interact directly with cyclins, determining a deregulation of the cell cycle and, therefore, the onset of the neoplastic phenotype.[5] In 1992, he moved to Philadelphia where he held the position of Assistant Professor at Temple University, first and then at Thomas Jefferson University. Since 2004, Giordano has been Full Professor of Anatomy and Pathological Histology at the University of Siena and currently holds the position of director of the Sbarro Institute for Cancer Research and Molecular Medicine and of the Center for Biotechnology in the College of Science and Technology at Temple University.[6]

Relations with Italy[edit]

Since January 1, 2004, Antonio Giordano has been full professor of Pathological Anatomy of the Department of Medical Biotechnologies of the University of Siena for exceptional scientific achievements.[7] Since June 2006 and for some years he has been President of the Scientific Committee of the Human Health Foundantion Onlus and president of the scientific committee of CROM (Oncological Research Center of Mercogliano-AV). There are also several collaborations with Italian Universities, such as the Universities of Rome, Naples, Palermo, Messina, Sassari.

Main scientific discoveries[edit]

In 1993, Antonio Giordano identified and cloned a new tumor suppressor gene, RB2 / p130, which has a primary function in the cell cycle by controlling correct DNA replication and essentially preventing the onset of cancer.[8] The alterations, at the level of these tumor suppressor genes, that is their non-expression or a malfunction, allow the neoplastic cells to multiply in an uncontrolled way. In the year 2000, a study of great international scientific impact on lung cancer was completed. The absolute novelty consists in the first example of setting up a gene therapy model that is tested in vivo on the guinea pig animal (mouse) in which a lung tumor was induced. Using the functionally active RB2 / p130 gene and, as a vector, a retrovirus, tumor growth has been shown to be drastically reduced after a single injection of RB2 / p130.[9] In 2001, another study examined a topic of great relevance and scientific relevance. The results of this study have opened the doors to a very suggestive key to interpreting tumor pathogenesis. The experiments always carried out on the animal (mouse) show, in fact, how RB2 / p130 can also work as an inhibitor of angiogenesis (the neoformation of vessels which, feeding the tumor, is the basis of neoplastic growth). In addition to RB2 / p130, Prof. Giordano has discovered two important "guardians" of the human genome CDK9 and CDK10[10] The results obtained by prof. Giordano with these studies have had a wide echo in the international press, as they open up important perspectives in the field of cancer treatment, allow us to glimpse completely new application possibilities compared to traditional surgical and chemotherapeutic treatments. In 2004 Giordano discovered NSPs (Novel Structure Proteins), a new protein structure with a potential role in the dynamics of the nucleus during cell division.[11] One protein in particular (Isoform NSP5a3a) is highly expressed in the cell lines of some tumors and could be a very useful tumor marker.

Health and Environment[edit]

In recent years Giordano has dedicated numerous efforts to studying the relationship between cancer and environmental pollution in the Italian region of Campania, linking his career as a researcher to that of a science communicator. He was among the first to report an increased incidence of various types of cancer in populations near illegal toxic waste sites. Not only has he published scientific articles on this subject but he has also committed himself to making these data known through two books on the subject, respectively "Campania, lterra di veleni"[12] and "Monnezze di stato" [13][14] edited by Denaro Libri and Minerva respectively. It also launched a petition to protect the environment, signed by over 500 researchers and people from various professional sectors. He has also been the promoter of numerous non-profit initiatives aimed at safeguarding the environment and human health (for more information on Antonio Giordano's contribution to the topic of Health and Environment, also read his interview with Italian scientists and scientists from North America Foundation).[15] Recently, as evidence of his commitment in this direction, Giordano was appointed Technical Consultant of the Public Prosecutor's Office of Avellino for the Isochimica[16] case and Scientific Director of the Mediterranea - Food and Wine Academy of Naples. He has carried out some scientific studies highlighting the anticancer properties of tomato.[17] Most recently he was the author and promoter of the Veritas[18] study, a pilot study aimed at clarifying the link between the onset of diseases and exposure to environmental pollutants.

Publications[edit]

Giordano is the author of over 600 scientific publications[19] on peer-reviewed journals, and holds numerous international patents relating to the discovery of new genes and new methods for the diagnosis and treatment of cancer.

  • Campania, terra dei veleni, Giulio Tarro (coautore), Napoli, Denaro Libri, 2011, ISBN 9788874440672. - libro bianco
  • Monnezza di Stato. Le terre dei fuochi nell'Italia dei veleni, Paolo Chiariello (coautore), Bologna, Minerva Edizioni,2015, ISBN 9788873817505. - libro inchiesta

Awards and Recognition[edit]

  • Cavaliere dell'Ordine al Merito della Repubblica Italiana (Italia) 2001

Commendatore OMRI BAR.svg

  • Commendatore dell'Ordine al Merito della Repubblica Italiana (Italia) 2010
  • Croce al Merito Melitense, onorificenza del Sovrano Militare Ordine di Malta

Notes[edit]

  1. ^ "SMOM, Riccardo Mastrangeli conferisce onorificenza al prof. Antonio Giordano". Dire.it (in Italian). January 7, 2018. Retrieved July 2, 2021.
  2. ^ Mayol, X.; Graña, X.; Baldi, A.; Sang, N.; Hu, Q.; Giordano, A. (September 1993). "Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain". Oncogene. 8 (9): 2561–2566. ISSN 0950-9232. PMID 8361765.
  3. ^ Baldi, A.; Boccia, V.; Claudio, P. P.; De Luca, A.; Giordano, A. (May 14, 1996). "Genomic structure of the human retinoblastoma-related Rb2/p130 gene". Proceedings of the National Academy of Sciences of the United States of America. 93 (10): 4629–4632. doi:10.1073/pnas.93.10.4629. ISSN 0027-8424. PMC 39329. PMID 8643454.
  4. ^ Claudio, P. P.; Howard, C. M.; Baldi, A.; De Luca, A.; Fu, Y.; Condorelli, G.; Sun, Y.; Colburn, N.; Calabretta, B.; Giordano, A. (November 1, 1994). "p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107". Cancer Research. 54 (21): 5556–5560. ISSN 0008-5472. PMID 7923196.
  5. ^ "Inquirer.com: Philadelphia local news, sports, jobs, cars, homes". www.inquirer.com. Retrieved July 2, 2021.
  6. ^ "Guest Editors". Oncogene. 25 (38): 5187–5188. August 2006. doi:10.1038/sj.onc.1209720. ISSN 1476-5594.
  7. ^ "Antonio Giordano MD, Ph.D. | Education Abroad and Overseas Campuses". studyabroad.temple.edu. Retrieved August 28, 2021.
  8. ^ "Combining Rb2 gene with radiation therapy quickens tumor cell death, Temple researchers find". EurekAlert!. Retrieved July 2, 2021.
  9. ^ "Guest Editors". Oncogene. 25 (38): 5187–5188. August 2006. doi:10.1038/sj.onc.1209720. ISSN 1476-5594.
  10. ^ Miller, Creighton J. (January 1, 2009). "Judicial Staff Directory". Reference Reviews. 23 (1): 23–24. doi:10.1108/09504120910925580. ISSN 0950-4125.
  11. ^ "Novel Structure Proteins discovered by Temple University researchers could play a role in apoptosis". Temple Now | news.temple.edu. July 24, 2008. Retrieved July 2, 2021.
  12. ^ "Libro Campania, terra di veleni - A. Giordano - Denarolibri | LaFeltrinelli". www.lafeltrinelli.it (in Italian). Retrieved July 2, 2021.
  13. ^ "Monnezza di Stato. La Terra dei fuochi nell'Italia dei veleni - Antonio Giordano - Paolo Chiariello - - Libro - Minerva Edizioni (Bologna) - Clessidra | IBS". www.ibs.it. Retrieved July 2, 2021.
  14. ^ "Lo studio. Terra dei fuochi e veleni. Nuove prove di contagio". www.avvenire.it (in Italian). December 17, 2019. Retrieved July 2, 2021.
  15. ^ "ISSNAF: un bel ponte di ricerca tra America e Italia". lavocedinewyork.com (in Italian). Retrieved July 2, 2021.
  16. ^ ""Ultima in Campania per sforamenti, metalli e diossina sopra norma: Avellino e l'Irpinia non possono permettersi una qualità dell'aria così scarsa": il monito dello scienziato Giordano - Orticalab.it". www.orticalab.it (in Italian). Retrieved July 2, 2021.
  17. ^ olgiati (December 16, 2020). "'Dieta del pomodoro' speranza contro il cancro allo stomaco". Adnkronos. Retrieved July 2, 2021.
  18. ^ Redazione. "Terra dei Fuochi. Studio "Veritas" rivela alto tasso di metalli pesanti nel sangue | JPress" (in Italian). Retrieved July 2, 2021.
  19. ^ "ANTONIO GIORDANO". scholar.google.com. Retrieved July 2, 2021.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Antonio_Giordano&oldid=1041421159"